At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 20 enrolled
Drug / intervention
Hydrocodone 5Mg/Acetaminophen 325Mg Tab +2 moredrug
Likely dose
Hydrocodone 5Mg/Acetaminophen 325Mg Tabfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Analysis of Hydrocodone Compared to Acetaminophen and Ibuprofen for Post-nail Procedure Analgesia
In Brief
A Phase 4 clinical trial evaluating Hydrocodone 5Mg/Acetaminophen 325Mg Tab, Acetaminophen 1000mg, and 1 other intervention for Nail Diseases and Nail Abnormality. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the safety and efficacy of ropivacaine and hydrocodone for nail-procedure associated pain management. The investigators hypothesize that ropivacaine with hydrocodone will be superior to ropivacaine with acetaminophen and ibuprofen for managing pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNail Diseases, Nail Abnormality
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2023202420252026
First PostedSep 2022
Enrollment StartNov 2022
Primary CompletionMay 2023
Study CompletionJun 2023
TodayJul 2026
First PostedSep 16, 2022
Enrollment StartNov 10, 2022
Primary CompletionMay 15, 2023
Study CompletionJun 1, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.8 years ago
Interventions
Hydrocodone 5Mg/Acetaminophen 325Mg Tabdrug
5 mg/325 mg tablet
Acetaminophen 1000mgdrug
1000 mg tablet
Ibuprofen 400 mgdrug
400 mg tablet